| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.35 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |